{"cik":2075320,"taxonomy":"us-gaap","tag":"OtherAssetsCurrent","label":"Other Assets, Current","description":"Amount of current assets classified as other.","entityName":"Polaryx Therapeutics, Inc.","units":{"USD":[{"end":"2025-12-31","val":27000,"accn":"0001213900-26-033064","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-24"},{"end":"2025-12-31","val":27000,"accn":"0001213900-26-056973","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15"},{"end":"2025-12-31","val":27000,"accn":"0001213900-26-089118","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13"},{"end":"2025-12-31","val":27000,"accn":"0001213900-26-118950","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-12","frame":"CY2025Q4I"},{"end":"2026-03-31","val":33000,"accn":"0001213900-26-056973","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15","frame":"CY2026Q1I"},{"end":"2026-09-30","val":18000,"accn":"0001213900-26-118950","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-12","frame":"CY2026Q3I"}]}}